OrthoPediatrics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, OrthoPediatrics stock has a consensus rating of "Buy" and an average price target of $24.67. The average 1-year stock price forecast is 33.14% higher than the current stock price, while the lowest is $17 (-8.26%) and the highest is $34 (+83.49%).

Price Target: $24.67 (+33.14%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$24.67	$24	$34
Change	-8.26%	+33.14%	+29.52%	+83.49%

Analyst Ratings

The average analyst rating for OrthoPediatrics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	5	5	5	5	5
Buy	3	3	3	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mathew Blackman TD Cowen	TD Cowen	Buy Maintains $23	Buy	Maintains	$23	+24.12%	Jun 12, 2026
Caitlin Roberts Canaccord Genuity	Canaccord Genuity	Buy Maintains $25	Buy	Maintains	$25	+34.92%	Jun 3, 2026
Ben Haynor Lake Street	Lake Street	Buy Reiterates $34	Buy	Reiterates	$34	+83.49%	May 1, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Buy Maintains $22	Buy	Maintains	$22	+18.73%	May 1, 2026
Rick Wise Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $22	Buy	Reiterates	$22	+18.73%	May 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

265.08M

from 236.35M

12.16%

from 236.35M

Revenue Next Year

296.52M

from 265.08M

11.86%

from 265.08M

EPS This Year

-1.05

from -1.00

EPS Next Year

-0.68

from -1.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	98.05M	122.29M	148.73M	204.73M	236.35M	265.08M
Revenue Growth	37.95%	24.72%	21.62%	37.65%	15.45%	12.16%
Gross Profit	73.40M	90.66M	111.25M	148.60M	172.66M	193.94M
Gross Margin	74.86%	74.14%	74.80%	72.58%	73.05%	73.16%
Operating Income	-17.87M	-21.79M	-25.77M	-29.52M	-29.00M	-20.11M
Net Income	-16.26M	1.26M	-20.97M	-37.82M	-39.65M	-26.40M
EPS	-	-	-	-	-1.00	-1.05
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	265.5M
Avg	265.1M
Low	264.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	12.3%
Avg	12.2%
Low	12.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.05
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-